drugset / Trial / NCT01587235
A Study to Evaluate the Efficacy and Safety of Vytorin Versus Standard Treatment of Other Statins in Moderate, Moderately High and High Risk Participants (MK-0653A-406)
RandomizedParallel-groupOpen-labelTreatment
Summary
This study will evaluate and compare the effectiveness of MK-0653 (Vytorin) to current standard treatment with other statins for the treatment of dyslipidemia in moderate, moderately-high and high-risk participants.
Timeline
- Start
- 2013-03
- Primary completion
- 2014-05
- Completion
- 2014-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ezetimibe/simvastatin | Unknown | 10 mg | Oral |
| Subject | Ezetimibe/simvastatin | Unknown | 20 mg | Oral |
| Subject | Ezetimibe/simvastatin | Unknown | 40 mg | Oral |